The unmet need of iron deficiency
We deliver innovative specialty pharmaceuticals that address a significant unmet need for patients suffering from iron deficiency, with or without anemia. Our lead product ACCRUFeR® (ferric maltol) is broadly indicated for use in adults across multiple therapeutic categories.
About Us
Shield is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead medicine ACCRUFeR®, a novel, stable, non-salt based oral therapy for adults with iron deficiency with or without anemia.
![Shield-AboutUs-720-540.jpg](https://www.shieldtherapeutics.com/application/files/cache/thumbnails/1be3e39cd811bd1b10d9e6ee7d71090b.jpg)
The content of all investor relations materials contained on this website are deemed to be correct at the time of issue/publication.